Navigation Links
Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008
Date:6/11/2008

AURORA, ON, June 11 /PRNewswire-FirstCall/ - Helix BioPharma Corp. (TSX, FSE: "HBP"), a biopharmaceutical company specializing in the field of cancer therapy, today announced its product development progress, quarterly highlights and financial results for the three and nine month periods ended April 30, 2008.

"During the quarter, we made significant advancements in the development of our lead clinical compounds," said John Docherty, President of Helix Biopharma. "We are currently developing plans for Topical Interferon to enter expanded Phase II/III clinical trials and we are anticipating L-DOS47 entering the clinic in a Phase I study."

HIGHLIGHTS

The Company's highlights for the quarter included the following events:

Clinical Development

- Helix met with the German Federal Institute for Drugs and Medical

Devices (BfArM) as a preliminiary step toward filing its CTA for a

planned large, randomized, placebo-controlled, double-blind Phase III

European clinical trial of Topical Interferon Alpha-2b in patients

with low-grade cervical lesions ("LSIL");

- Helix received approval from the Swedish Medical Products Agency for

a clinical protocol amendment to expand its Topical Interferon

Alpha-2b AGW clinical trial to sites in Germany;

- The Prominent German dermatologist, Professor Dr. med. Eggert

Stockfleth of the Department of Dermatology, Skin Cancer Center

Charite, Universitatsmedizin Berlin, was engaged by Helix to act as

the German co-ordinating investigator for the expanded AGW clinical

trial in Germany;

GMP Manufacturing

- Contract Pharmaceuticals Limited Niagara was engaged by Helix to

further scale-up the Topical Interferon Alpha-2b GMP production

process in anticipation of conducting clinical trials in the U.S. and

Europe in patients with LSIL;

-
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
2. Helix BioPharma reports Q2 2008 highlights, financial results
3. Helix BioPharma shareholders vote in favour of management
4. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
5. Helix BioPharma closes $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma announces $16.9 million private placement of common shares
8. Helix BioPharma Corp. announces management changes
9. Helix BioPharma Corp. announces fiscal 2007 results
10. Helix BioPharma Chairman resigns
11. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Two champions of ... their sponsorship of an annual competition for middle and ... access to, innovative STEM study. The competition presents students ... Tests of Engineering Aptitude, Mathematics, and Sciences is ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched Sound ... Patients listen to sound therapy that is tailor-made for ... to months, their tinnitus volume decreases. , AudioNotch has previously ... Notched White Noise. Now, AudioNotch is pleased to announce to ...
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations and ... the United States and Europe ... JD, is returning to the firm,s Washington, D.C. ... more than two years of service as Associate Commissioner for the ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Former FDA Associate Commissioner Returns To 3D Communications 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... (Frankfurt Stock Exchange: EVT) today announced that Jörn,Aldag, President & CEO, ... Date: Tuesday, ... 11.45 am EST (05.45 pm CET/04.45 pm GMT) Location: ... will be available on the Evotec website at, http://www.evotec.com - ...
... . , ANN ARBOR, Mich.---A new energy-capturing knee ... a portable GPS locator, a cell phone, a motorized ... University of Michigan shows. , A report on the ... the journal Science. Authors include researchers from Simon Fraser ...
... BRISBANE, Calif., Feb. 7 InterMune, Inc.,(Nasdaq: ITMN ) ... ended December 31, 2007. The company also provided 2008,financial guidance ... the Fourth Quarter 2007, InterMune reported a net loss ... per share, compared with a net loss of $21.5 million, ...
Cached Biology Technology:Knee brace generates electricity from walking 2InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 2InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 3InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 4InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 5InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 6InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 7InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 8InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 9InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 10InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 11
(Date:4/17/2014)... University (ANU), have developed a new way to ... the past 5.3 million years., The findings will ... ages over the past two million years, and ... levels, global temperatures and sea levels., The team ... the National Oceanography Centre (NOC) in the United ...
(Date:4/16/2014)... species of yellow-shouldered bats have been unearthed by scientists at the ... History and described in the open access journal ZooKeys ... are part of a recent discovery of three bats hidden ... to be officially announced. , Up until recently the genus ...
(Date:4/16/2014)... Doucet of the Centre INRSInstitut Armand-Frappier has just received a ... the amount of nearly US$600,000. The 5-year grant is to ... RNases and to explore their biomedical potential in the field ... , "Receiving a grant at this level is an ...
Breaking Biology News(10 mins):Ancient sea-levels give new clues on ice ages 2Two new species of yellow-shouldered bats endemic to the Neotropics 2High-level NIH grant goes to professor Nicolas Doucet of INRS 2
... Embryonic stem cells, prized for their astonishing ability to apparently ... their identities in part by interacting with their surroundings - ... laboratory dish, University of Florida scientists report. , Using an ... McKnight Brain Institute have begun to answer one of the ...
... fact, beneficial microbes could represent the future of medicine, ... in humans and animals from diarrhea and eczema to ... released by the American Academy of Microbiology, Probiotic Microbes: ... used to treat a range of clinical conditions that ...
... have discovered a new gene that could lead to ... diabetes. , The gene, called SLIRP, was discovered by ... Research's (WAIMR) Laboratory for Cancer Medicine, led by Professor ... at Baylor College of Medicine in Texas. , "When ...
Cached Biology News:Birds going extinct faster due to human activities 2Birds going extinct faster due to human activities 3Report focuses on the role good microbes play in future medicine 2Gene discovery opens door to tackling disease 2
... protein ribonuclease inhibitor that noncovalently binds and inactivates ... seen with RNase 1, T1, T2, H, U1, ... placental ribonuclease inhibitor in that it has a ... release active RNase in the absence of DTT ...
... (Chemical Inkjet Printer) is a revolutionary ... and Protein Macroarray Analysis, developed in ... The strategy compliments established protocols in ... the proteins isoelectric point and apparent ...
... The BIOLASE Core Kit ... to perform polymerase assays on ... templates. In addition to dNTPs, ... on our widely used BIOLASE ...
Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
Biology Products: